[
  {
    "title": "Biogen Faces Uncertain Outlook for Alzheimer's Drug But Pipeline Supports Growth, RBC Says",
    "link": "https://finance.yahoo.com/news/biogen-faces-uncertain-outlook-alzheimer-171712526.html",
    "publisher": "MT Newswires",
    "date": "2026-02-26T17:17:12Z",
    "type": "STORY"
  },
  {
    "title": "ETFs to Buy as NVIDIA Shares Gain Following Q4 Earnings Beat",
    "link": "https://finance.yahoo.com/news/etfs-buy-nvidia-shares-gain-165200077.html",
    "publisher": "Zacks",
    "date": "2026-02-26T16:52:00Z",
    "type": "STORY"
  },
  {
    "title": "Eli Lilly Says Orforglipron Outperforms Oral Semaglutide in Phase 3 Trial",
    "link": "https://finance.yahoo.com/news/eli-lilly-says-orforglipron-outperforms-153805407.html",
    "publisher": "MT Newswires",
    "date": "2026-02-26T15:38:05Z",
    "type": "STORY"
  },
  {
    "title": "Jim Cramer Recommends Eli Lilly over Novo Nordisk",
    "link": "https://finance.yahoo.com/news/jim-cramer-recommends-eli-lilly-145642576.html",
    "publisher": "Insider Monkey",
    "date": "2026-02-26T14:56:42Z",
    "type": "STORY"
  },
  {
    "title": "Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore",
    "link": "https://www.fool.com/investing/2026/02/26/hims-hers-telehealth-growth-story-for-young-invest/",
    "publisher": "Motley Fool",
    "date": "2026-02-26T12:37:00Z",
    "type": "STORY"
  },
  {
    "title": "Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial",
    "link": "https://www.biopharmadive.com/news/lilly-orforglipron-rybelsus-diabetes-study-results-glp-1/813209/",
    "publisher": "BioPharma Dive",
    "date": "2026-02-26T12:10:00Z",
    "type": "STORY"
  },
  {
    "title": "Novo Nordisk's China Obesity Drug Cuts Nearly One-Fifth Of Body Weight",
    "link": "https://finance.yahoo.com/news/novo-nordisks-china-obesity-drug-043113091.html",
    "publisher": "Benzinga",
    "date": "2026-02-26T04:31:13Z",
    "type": "STORY"
  },
  {
    "title": "Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies",
    "link": "https://www.fool.com/coverage/stock-market-today/2026/02/25/stock-market-today-feb-25-novo-nordisk-dips-after-announcing-usd2-1-billion-partnership-with-vivtex-for-oral-drug-delivery-technologies/",
    "publisher": "Motley Fool",
    "date": "2026-02-25T23:12:08Z",
    "type": "STORY"
  },
  {
    "title": "Novo Nordisk Resets Obesity Strategy After CagriSema Miss And Vivtex Deal",
    "link": "https://finance.yahoo.com/news/novo-nordisk-resets-obesity-strategy-221240820.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-25T22:12:40Z",
    "type": "STORY"
  },
  {
    "title": "Eli Lilly acquires Orna Therapeutics for $2.4B to disrupt CAR-T market",
    "link": "https://www.thestreet.com/investing/stocks/eli-lilly-acquires-orna-therapeutics-for-2-4b-to-disrupt-car-t-market",
    "publisher": "TheStreet",
    "date": "2026-02-25T20:13:00Z",
    "type": "STORY"
  }
]